Meyka Pro banner
SunLink Health Systems, Inc.

SunLink Health Systems, Inc. (AMEX: SSY) Stock Competitors & Peer Comparison

See SSY's competitors and their performance on the AMEX and across the wider stock market.

SSYAMEX
HealthcareMedical - Pharmaceuticals
$1.11
$0.16(16.15%)
U.S. Market opens in 12h 39m

Peer Comparison Table: Medical - Pharmaceuticals Industry

Detailed financial metrics including price, market cap, P/E ratio, and more for SSY and its AMEX peers.

SymbolPriceChange %Market CapP/E RatioEPSDividend Yield
SSY$1.12+16.15%7.9M-2.86-$0.39+8.97%
RPRX$56.77-0.86%25.2B10.81$5.25+1.60%
CORT$110.77+2.61%12B316.49$0.35N/A
WBA$11.98+0.50%10.4B-1.64-$7.29+4.17%
LQDA$90.22+0.89%8B644.43$0.14N/A
KNSA$76.06-0.59%5.8B84.51$0.90N/A
TRLV$8.75-2.78%1.5B-20.83-$0.42N/A
HROWL$25.61+0.19%1.4BN/AN/AN/A
HROWM$26.03-0.08%1.3BN/AN/AN/A
CUVL$6.68-0.65%336.6MN/AN/AN/A
1

Stock Comparison

Select a stock to compare (requires JavaScript). Showing default comparison.

Royalty Pharma plc (NASDAQ: RPRX)

SSY vs RPRX Comparison August 2026

SunLink Health Systems, Inc. (AMEX: SSY) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SSY stands at 7.9M. In comparison, RPRX has a market cap of 25.2B. Regarding current trading prices, SSY is priced at $1.12 on the AMEX, while RPRX trades at $56.77.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SSY currently has a P/E ratio of -2.86, whereas RPRX's P/E ratio is 10.81. In terms of profitability, SSY's ROE is -0.09%, compared to RPRX's ROE of +0.11%. Regarding short-term risk, SSY is more volatile compared to RPRX. This indicates higher risk in terms of short-term price fluctuations for SSY.Check RPRX's competition here

Stock price comparison of stocks in the Healthcare Sector

Loading...

Frequently Asked Questions